Анестезия и педиатрия - Джордж А.Г.
ISBN 5-225-03821-2
Скачать (прямая ссылка):
52. Veiburt! MP. Ocrlemans FTJJ, van Bennekom CA et al: hi vivo induced malignant hyperthermia in pigs. I. Physiological and biochemical changes and the influence of dantrolene sodium. Acta Anaesthesiol Scand 29:1. 1984
53. Gronert GA. Theye RA: Halothane-indnced porcine malignant hyperthermia: metabolic and hemodynamic changes. Anesthesiology 44:36. 1976
54. Fuchs F: Thermal inactivation of the calcium regulatory mechanism of human skeletal muscle actomyosin: u possible contributing factor in the rigidity of malignant hyperthermia. Anestlwsiology 42:584. 1975
55. Britt BA, Endrenyi L. Petei* PL ct al: Screening of malignant hyperthermia susceptible families by creatine phos-
phokinase measurement and other clinical investigations. Cun Anaesth Soc J 23:263, 1976
56. Halsall PJ, Cain PA, Ellis FR: Retrospective analysis of anaesthetics received by patients before susceptibility to malignant hyperpyrexia was recognized. Br J Anaesth 51:949, 1979
57. Hull MJ, Webster WW, Gat* E: The cflccis of pentobarbital on 2,4-dinitrophcnol induccd malignant hyperthermia during halothane general anesthesia in dogs. J Oral Smg 29:640. 1971
58. Hall CM, Lncke JN. Lister 0: Porcine malignant hyperthermia IV: neuromuscular blockade. Br J Anaesth 48:1135, 1976
59. Jones DE, Ryan JF. Taylor В et al: Pancuronium in large doses protects susceptible swine from halothane induced malignant hyperthermia. Anesthesiology 63:A344. 1985
60. Nelson ТЕ: Porcine malignant hyperthermia: critical temperatures for in vivo and in vitro responses. Anesthesiology 73:449. 1990
61. latzzo PA. Kehler CH. Carr RJ, ct al: Prior hypothermia attenuates malignant hyperthermia in susccptiblc swine. Anesth Analg 82:782, 1996
62. Sewall K, Flowerdcw RM, Bromberger P: Severe muscular rigidity at birth: malignant hyperthermia syndrome? Can Anaesth Soc J 27:279, 1980
63. Schmitt HP, Simmendinger HJ, Wagner H ct al: Severe morphological changes in skeletal muscles of a five-month old infant dying from an anesthetic complication with general muscle rigidity. Ncuropudiatrie 6:102, 1975
64. Faust DK. Gcrgis SD, Sokoll MO: Management of suspected malignant hyperpyrexia in an infant. Anesth Analg 58:33. 1979
65. Dempsey WC, Mayhew JF, Metz PS. Southern ТЕ: Malignant hyperthermia during repair of a cleft lip in a 6-month-old infant, with survival. Ann Plost Surg 1:315, 1978
66. Mayhew JF, Rudolph J, Tobey RE: Malignant hyperthermia in a six month old infant: a case report. Anesth Analg 57:262, 1978
67. Britt BA, Kwong FH-F, Endrenyi L: The clinical and laboratory features of malignant hyperthermia management — a review, p. 9. In Hcnschei ED (ed): Malignant Hyperthermia: Current Concepts. N, Applcton-Ccntury-CrolK East Norwalk. CT, 1977
68. Glassenberg R. Cohen H: Intravenous dantrolene in a pregnant malignant hyperthermia susceptible (MHS) patient. Anesthesiology 6|:A404, 1984
69. M orison DH: Placcntal transfer of dantrolene | letter | Anesthesiology 59:265, 1983
70. Britt BA, Lochcr WG. Kalow W: Hereditary aspects of malignant hyperthermia. Can Anaesih Soc J 16:89, 1969
71. Denborough MA, Forster JFa. Lovell RRH et al: Anaesthetic deaths in a family. J Anaesth 34:395, 1962
72. Lutsky I, Witkowski J. Hcnschei EO: HLA typing in a family prone to malignant hyperthermia. Anesthesiology 56:224, 1982
73. Mickelson J R, Gallant EM, Littcrer LA et al: Abnormal sarcoplasmic reticulum ryanodine receptor in malignant hyperthermia. J Biol Chem 263:9310, 1988
74. Deufel T, Golla A, lies D ct al: Evideuce for genctic heterogeneity of malignant hyperthermia susceptibility. Am J Hum Genet 50:1151, 1992
75. King JO. Denborough MA. Zapf PW: Inheritance of malignant hyperpyrexia. Lancet 1:365. 1972
76. King JO, Denborough MA: Anesthetic- induccd malignant hyperpyrexia in children. J Pediatr 83:37, 1973
77. McPherson EW, Taylor CA Jr: The King syndrome: malignant hyperthermia, myopathy, and multiple anomalies. Am J Med Genet 8:159, |98l
78. Kousseff BG, Nichols P: A new autosomal recessive syndrome of Noonan-like phenotype, myopathy with con-
genital contractures and malignant hyperthermia. Proc Greenwood Genet Center 4:110, 1985
79. Saul RA, Stevenson RE, Roberts TL: A female with the King syndrome in a family with elevated CPK levels. Proc Greenwood Genet Center 3:7, 19X4
80. Hunter A, Pinsky L An evaluation of the possible association of malignant hyperpyrexia with (lie Noonan syndrome using scrum creatine phospho kinase levels. J Pediatr 86:412, 1975
HI. Eng OD. Epstein BS, Engel WK et al: Malignant hyperthermia and central core disease in a child with congenital dislocating hips. Arch Neurol 35:189, 1978
82. GuDotla F, Pavone L, La Rosa M, Grasso A: Minicorc myopathy. Klin Wochenschr 60:1351, 1982
83. Frank JP, Haniti Y, Butler li et al: Central core disease and malignant hyperthermia syndrome. Ann Neurol 7:11,
1980
84. Brandt A, SchlcithofT L, Jurkat-Rott K, et al: Screening of the ryanodine receptor gene in 105 malignant hyperthermia families: novel mutations and concordance with
